Thursday, 5 April 2018
BioLargo Spotlight: Odor-No-More’s CupriDyne Clean Achieves Systematic Local Adoption Through National Accounts
We just received good news that our odor control products will be deployed at seven new locations across Southern California, representing a local area market for one of our national accounts, and an example of our top-down strategy for systematic local adoption.
As a result of our continued success serving this national account, we were invited to meet with its area managers to discuss the use of our products across their facilities. Those introductions led, in turn, to direct work with their local operators in Southern California. This win is a great example of our top-down marketing strategy leading to increased local adoption.
Since we’re adding more clients, we’re adding more staff. We reported in our 10-K that we had hired two new account executives. We’ve now added an internal sales representative and are also adding manufacturing and client support staff.
We’re not just selling products to these clients, we’re also beginning to bid on expanded service contracts with them. Our engineering team has submitted design, construct and install bids for misting systems, and we will report more on that as information becomes available. We believe opportunities like these will continue to expand across the nation. These wins are a result of us earning our customers’ trust and delivering quality results and service, and we hope are a precursor to further expanding our sales nationally. We reported in our 10-K that our annual revenue from product sales increased 123% in 2017. We believe this growth will accelerate in 2018, and we intend to continue our blog posts of these small victories.
Our attorneys remind us that while we believe these developments are important and that these small victories could add up and lead to big victories, at this stage they do not rise to the level of an official material disclosure. Naturally, as the size and magnitude of these developments become material, we will report that information in an 8-K and in our regular SEC filings.
What is a BioLargo Spotlight?
It’s an exciting time at BioLargo. We’re moving fast, and it can be difficult to keep our stockholders and the investing public informed of our progress. In light of this, we will be posting a series of short articles titled “BioLargo Spotlight”, highlighting certain business activities and other important information in between our required SEC filings. Of course, these do not replace our public filings, which contain more complete information than can be delivered in this forum, and thus we urge you to carefully read and rely on those filings for definitive information, and to review our risk factors and caution regarding forward-looking statements. We are optimistic about our business as we work hard to continue to grow and ultimately generate profits for our stockholders.
Safe Harbor Statement
The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, the risks and uncertainties included in BioLargo's current and future filings with the Securities and Exchange Commission, including those set forth in BioLargo's Annual Report on Form 10-K.
President and CEO